(Q46030893)

18 December 2017

title

Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome. (English)

1 reference

18 December 2017

1 reference

1 reference

Shalini V Kaushik

1

1 reference

18 December 2017

Eric P Plaisance

2

1 reference

18 December 2017

Teayoun Kim

3

1 reference

18 December 2017

Edmond Y Huang

4

1 reference

18 December 2017

A Jack Mahurin

5

1 reference

18 December 2017

Peter W Grandjean

6

1 reference

18 December 2017

Suresh T Mathews

7

1 reference

18 December 2017

publication date

1 July 2009

1 reference

18 December 2017

Diabetes - Metabolism: Research and Reviews

published in

1 reference

18 December 2017

volume

25

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

page(s)

427-434

1 reference

18 December 2017

cites work

The metabolic syndrome

1 reference

7 January 2021

The myth of the metabolic syndrome

1 reference

7 January 2021

The humoral side of insulin resistance

1 reference

7 January 2021

Metabolism: A is for adipokine

1 reference

7 January 2021

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

1 reference

7 January 2021

Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor

1 reference

7 January 2021

Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes

1 reference

7 January 2021

Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects

1 reference

7 January 2021

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

1 reference

7 January 2021

Electrophoretic and isoelectric focusing analysis of human recombinant alpha 2-HS glycoprotein produced in insect cells: analysis of the post-translational events

1 reference

7 January 2021

Effect of phosphorylated rat fetuin on the growth of hepatocytes in primary culture in the presence of human hepatocyte-growth factor. Evidence that phosphorylated fetuin is a natural modulator of hepatocyte-growth factor

1 reference

7 January 2021

Plasma alpha2-HS glycoprotein concentrations in patients with acute myocardial infarction quantified by a modified ELISA

1 reference

7 January 2021

Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

1 reference

7 January 2021

Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.

1 reference

7 January 2021

alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action

1 reference

7 January 2021

AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects

1 reference

7 January 2021

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study

1 reference

7 January 2021

Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene

1 reference

7 January 2021

Fetuin-null mice are protected against obesity and insulin resistance associated with aging.

1 reference

7 January 2021

Fetuin-A and incident diabetes mellitus in older persons

1 reference

7 January 2021

Plasma fetuin-A levels and the risk of type 2 diabetes

1 reference

7 January 2021

CCAAT enhancer binding protein β and hepatocyte nuclear factor 3β are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression

1 reference

7 January 2021

Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Correction of low HDL cholesterol to reduce cardiovascular risk: practical considerations relating to the therapeutic use of prolonged-release nicotinic acid (Niaspan).

1 reference

7 January 2021

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

1 reference

7 January 2021

Increased total and high-molecular weight adiponectin after extended-release niacin

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Effect of liver fat on insulin clearance

1 reference

7 January 2021

Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity.

1 reference

7 January 2021

Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease.

1 reference

7 January 2021

Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass.

1 reference

7 January 2021

Association of serum fetuin-A with carotid arterial stiffness.

1 reference

7 January 2021

Vascular calcification and fetuin-A deficiency in chronic kidney disease

1 reference

7 January 2021

The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome

1 reference

7 January 2021

Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content

1 reference

7 January 2021

Effects of nicotinic acid on insulin sensitivity and blood pressure in healthy subjects.

1 reference

7 January 2021

Extended-release niacin raises adiponectin and leptin

1 reference

7 January 2021

Preferential increase in high-molecular weight adiponectin after niacin

1 reference

7 January 2021

Fetuin-A induces cytokine expression and suppresses adiponectin production

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.967

1 reference

18 December 2017

PubMed ID

19405044

1 reference

18 December 2017